Skip to main content

Advertisement

Table 3 Drug acquisition costs related to non-adherence with different number of dispensed drugs in Sweden 2006.

From: Non-adherence to drug therapy and drug acquisition costs in a national population - a patient-based register study

    DDD   Acq cost   PNA Prescribed SNA Cost related non-adherence
Therapy Age DP million % million % rate drug cost rate million %
Conti. 0-19 DP1-4 106 2 329 1, 4 3 339 40 126 38, 1
   DP5-9 56 1, 1 224 1 2 229 50 110 49, 0
   DP10-14 13 0, 2 61 0, 3 2 63 50 30 49, 0
   DP15- 4 0, 1 36 0, 2 2 37 60 21 59, 2
  20-49 DP1-4 273 5, 2 1151 5 4 1199 40 432 37, 5
   DP5-9 236 4, 5 1301 5, 6 4 1356 50 624 47, 9
   DP10-14 106 2 610 2, 6 4 636 50 292 47, 9
   DP15- 81 1, 5 479 2, 1 4 499 60 279 58, 3
  50-69 DP1-4 250 4, 8 855 3, 7 3 882 40 326 38, 1
   DP5-9 532 10, 1 1820 7, 9 3 1876 50 882 48, 5
   DP10-14 338 6, 4 1286 5, 6 3 1326 50 623 48, 5
   DP15- 288 5, 5 1305 5, 6 3 1346 60 767 58, 8
  70- DP1-4 118 2, 3 328 1, 4 2 335 40 127 38, 8
   DP5-9 516 9, 8 1276 5, 5 2 1302 50 625 49, 0
   DP10-14 525 10 1337 5, 8 2 1364 50 655 49, 0
   DP15- 485 9, 2 1398 6 2 1426 60 827 59, 2
Short- 0-19 DP1-4 36 0, 7 550 2, 3 2 560 20 101 18, 3
term   DP5-9 20 0, 4 263 1, 1 2 268 30 75 28, 5
   DP10-14 5 0, 1 87 0, 4 2 88 40 33 38, 4
   DP15- 2 0 38 0, 2 2 39 50 19 49, 3
  20-49 DP1-4 97 1, 8 796 3, 4 4 830 20 133 16, 7
   DP5-9 98 1, 8 764 3, 3 4 795 30 207 27, 1
   DP10-14 46 0, 9 363 1, 5 4 379 40 136 37, 6
   DP15- 39 0, 7 310 1, 3 4 323 50 149 47, 9
  50-69 DP1-4 94 1, 8 562 2, 5 3 579 20 98 17, 5
   DP5-9 169 3, 2 1000 4, 3 3 1031 30 278 27, 8
   DP10-14 113 2, 2 692 2, 9 3 714 40 264 38, 2
   DP15- 111 2, 2 734 3, 2 3 756 50 355 48, 4
  70- DP1-4 39 0, 7 191 0, 8 2 196 20 35 18, 5
   DP5-9 142 2, 8 679 2, 9 2 693 30 194 28, 6
   DP10-14 155 3 763 3, 3 2 778 40 296 38, 7
   DP15- 161 3 868 3, 8 2 886 50 425 49, 0
No DDD   0 0 697 3   718 50 309 44, 3
All    5254 100 23153 99, 9   23848   9855 42, 6
  1. DDD, acquisition costs for dispensed drugs (Acq cost), rate of primary non-adherence (PNA), estimated acquisition costs for prescribed drugs, rate of secondary non-adherence (SNA)and drug acquisition costs related to non-adherence for individuals with varying therapies, age and different number of dispensed drugs in Sweden in 2006